Deborah Morena

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity.

Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 03, 2023

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma.

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma.

Journal: Cancers

Published: April 20, 2021

Future perspectives from lung cancer pre-clinical models: new treatments are coming?

Future perspectives from lung cancer pre-clinical models: new treatments are coming?

Journal: Translational lung cancer research

Published: January 25, 2021

Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma.

Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma.

Journal: International journal of molecular sciences

Published: May 31, 2020

CircNT5E/miR-422a: a new circRNA-based ceRNA network in glioblastoma.

CircNT5E/miR-422a: a new circRNA-based ceRNA network in glioblastoma.

Journal: Translational cancer research

Published: October 16, 2018

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.

Journal: Oncoimmunology

Published: July 05, 2017

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.

Journal: Oncotarget

Published: June 14, 2016

Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma.

Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma.

Journal: Cancer research

Published: March 11, 2016

Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes.

Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes.

Journal: eLife

Published: October 09, 2015

The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia.

The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia.

Journal: Oncology letters

Published: September 11, 2015

SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.

SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.

Journal: Cell cycle (Georgetown, Tex.)

Published: February 04, 2015

The vitamin D receptor inhibits the respiratory chain, contributing to the metabolic switch that is essential for cancer cell proliferation.

The vitamin D receptor inhibits the respiratory chain, contributing to the metabolic switch that is essential for cancer cell proliferation.

Journal: PloS one

Published: August 09, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026